Brief: Context Therapeutics Reports Full Year 2025 Operating And Financial Results
23/03/2026 20:34
March 23 (Reuters) - Context Therapeutics Inc CNTX.O: CONTEXT THERAPEUTICS REPORTS FULL YEAR 2025 OPERATING AND FINANCIAL RESULTS CONTEXT THERAPEUTICS: CASH AND CASH EQUIVALENTS OF $66 MILLION AS OF DECEMBER 31, 2025 EXPECTED TO FUND OPERATIONS INTO MID-2027 Source text: ID:nGNX3qp7KS Further company coverage: CNTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Context Therapeutics
See all newsContext Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Context Therapeutics Q2 net loss widens on higher R&D costs
Context Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Context Therapeutics Announces Positive Interim Efficacy And Safety Results From Ongoing Phase 1 Clinical Trial For CTIM-76
Brief: Context Therapeutics Enters Into License Agreement Amendment With BioAtla For CT-202